AN2 Therapeutics Initiates Phase 2 Trial of Epetraborole for Difficult-to-Treat M. abscessus Lung Disease AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative small molecule therapies using its…
PepGen Reports Positive Topline Results from Lowest-Dose (5 mg/kg) MAD Cohort in Phase 2 FREEDOM2 Study, Highlighting Safety, Splicing, and vHOT Outcomes PepGen has reported encouraging topline results from the…
Sensei Biotherapeutics Reports Full-Year 2025 Results, Advances PIKTOR Following Faeth Acquisition and $200 Million Financing Sensei Biotherapeutics, has reported its financial results for the full year ended December 31, 2025,…
Projects $170 Million EBITDA Improvement and Path to Profitability in 2026 P3 Health Partners a physician-led and patient-centered population health management organization, has released its financial results for the fourth…
Incyte Strengthens Leadership Team with Key Senior Appointments to Drive Long-Term Growth Incyte has announced a series of strategic appointments to its senior management team, reinforcing its leadership structure as…
Artesia General Hospital Leverages Ambient AI to Transform Rural Healthcare Delivery ARTESIA,General Hospital (AGH), a leading healthcare provider serving southeastern New Mexico, is taking a major step forward in modernizing…
Medpace Conference Call Scheduled for April 23 with Webcast and Replay Available on Investor Website Medpace Holdings, Inc. has announced the timing for the release of its financial results for…
Johnson & Johnson Secures U.S. Food and Drug Administration Approval for TECNIS PureSee Intraocular Lens, Expanding Vision Care Options for U.S. Cataract Patients Johnson & Johnson announced U.S. Food and Drug…
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan Curatis Holding AG and Neupharma Co., Ltd. a…
Fierce Healthcare Names SpotitEarly a “Fierce 15” Company of 2026 SpotitEarly, a multi-cancer early detection startup that uses AI and trained canines to identify cancer odor signatures in breath samples,…
NRC Health Announces $60 Million Share Repurchase Authorization National Research Corporation, doing business as NRC Health, has announced that its Board of Directors has approved a new stock repurchase program…
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era MindWalk Holdings Corp. a bio-native AI company, today announced B Cell Llama™, a platform…